Vault-13

ACT CAPITAL MANAGEMENT, LLC

WAYNE, PA · CIK 1442273 · 13F filing filed 2022-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$71.5m reported value -24.4% vs Q1 2022
78positions
68.6%in top 10
11 new 4 added 27 reduced 18 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 STAAR SURGICAL CO COM PAR $0.01 STAA STAA 228,900 $16.2m22.71% 22.71% ReducedShares held: Q3 2021 268.2k, Q4 2021 258.1k, Q1 2022 238.1k, Q2 2022 228.9k -9.2k -9,200 -3.9%
2 EXXON MOBIL CORP COM XOM XOM 56,900 $4.9m6.82% 6.82% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 56.9k
3 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 135,000 $4.8m6.65% 6.65% ReducedShares held: Q3 2021 194.0k, Q4 2021 210.5k, Q1 2022 201.0k, Q2 2022 135.0k -66.0k -66,000 -32.8%
4 DEVON ENERGY CORP NEW COM DVN DVN 82,500 $4.5m6.36% 6.36% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 44.5k, Q2 2022 82.5k +38.0k +38,000 85.4%
5 KRYSTAL BIOTECH INC COM KRYS KRYS 59,000 $3.9m5.42% 5.42% UnchangedShares held: Q3 2021 40.0k, Q4 2021 59.0k, Q1 2022 59.0k, Q2 2022 59.0k
6 ARCTURUS THERAPEUTICS HLDGS COM ARCT ARCT 226,600 $3.6m4.99% 4.99% ReducedShares held: Q3 2021 455.3k, Q4 2021 479.4k, Q1 2022 253.3k, Q2 2022 226.6k -26.7k -26,700 -10.5%
7 CLEARSIDE BIOMEDICAL INC COM COM 2,288,200 $3.4m4.70% 4.70% ReducedShares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.3m -170.4k -170,400 -6.9%
8 CHEVRON CORP NEW COM CVX CVX 19,500 $2.8m3.95% 3.95% AddedShares held: Q3 2021 16.0k, Q4 2021 12.5k, Q1 2022 3.5k, Q2 2022 19.5k +16.0k +16,000 457.1%
9 ADTRAN INC COM ADTN ADTN 150,000 $2.6m3.68% 3.68% AddedShares held: Q3 2021 0, Q4 2021 115.0k, Q1 2022 85.0k, Q2 2022 150.0k +65.0k +65,000 76.5%
10 IDEAYA BIOSCIENCES INC COM IDYA IDYA 173,500 $2.4m3.35% 3.35% UnchangedShares held: Q3 2021 173.5k, Q4 2021 173.5k, Q1 2022 173.5k, Q2 2022 173.5k
11 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 250,000 $1.6m2.20% 2.20% UnchangedShares held: Q3 2021 158.5k, Q4 2021 158.5k, Q1 2022 250.0k, Q2 2022 250.0k
12 ENVVENO MEDICAL CORPORATION COM COM 401,200 $1.5m2.12% 2.12% UnchangedShares held: Q3 2021 0, Q4 2021 262.5k, Q1 2022 401.2k, Q2 2022 401.2k
13 INMUNE BIO INC COM INMB INMB 160,500 $1.4m1.98% 1.98% ReducedShares held: Q3 2021 275.0k, Q4 2021 230.5k, Q1 2022 230.5k, Q2 2022 160.5k -70.0k -70,000 -30.4%
14 ENERGY TRANSFER L P COM UT LTD PTN ET ET 127,800 $1.3m1.78% 1.78% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 127.8k
15 UNITY SOFTWARE INC COM U U 26,300 $968.0k1.35% 1.35% NewShares held: Q3 2021 2.0k, Q4 2021 0, Q1 2022 0, Q2 2022 26.3k
16 STRATASYS LTD SHS SSYS SSYS 50,000 $937.0k1.31% 1.31% ReducedShares held: Q3 2021 27.5k, Q4 2021 93.5k, Q1 2022 138.5k, Q2 2022 50.0k -88.5k -88,500 -63.9%
17 VITAL ENERGY INC COM VTLE VTLE 12,800 $882.0k1.23% 1.23% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 12.8k
18 AFFIMED N V COM COM 308,800 $855.0k1.20% 1.20% UnchangedShares held: Q3 2021 281.3k, Q4 2021 308.8k, Q1 2022 308.8k, Q2 2022 308.8k
19 LANTHEUS HLDGS INC COM LNTH LNTH 12,900 $852.0k1.19% 1.19% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 40.0k, Q2 2022 12.9k -27.1k -27,100 -67.8%
20 ICAD INC COM NEW ICAD ICAD 205,000 $820.0k1.15% 1.15% ReducedShares held: Q3 2021 224.5k, Q4 2021 324.1k, Q1 2022 294.5k, Q2 2022 205.0k -89.5k -89,500 -30.4%
21 MYOVANT SCIENCES LTD COM MYOV MYOV 65,000 $808.0k1.13% 1.13% ReducedShares held: Q3 2021 85.0k, Q4 2021 85.0k, Q1 2022 85.0k, Q2 2022 65.0k -20.0k -20,000 -23.5%
22 CF INDS HLDGS INC COM CF CF 9,000 $772.0k1.08% 1.08% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 9.0k
23 INHIBIKASE THERAPEUTICS INC COM IKT IKT 937,500 $696.0k0.97% 0.97% ReducedShares held: Q3 2021 1.0m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 937.5k -139.0k -139,000 -12.9%
24 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 24,500 $696.0k0.97% 0.97% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 24.5k
25 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 51,000 $513.0k0.72% 0.72% ReducedShares held: Q3 2021 180.0k, Q4 2021 188.5k, Q1 2022 67.5k, Q2 2022 51.0k -16.5k -16,500 -24.4%
26 CHAMPIONS ONCOLOGY INC COM NEW CSBR CSBR 62,500 $500.0k0.70% 0.70% UnchangedShares held: Q3 2021 58.5k, Q4 2021 62.5k, Q1 2022 62.5k, Q2 2022 62.5k
27 DIAMONDBACK ENERGY INC COM FANG FANG 4,000 $485.0k0.68% 0.68% NewShares held: Q3 2021 0, Q4 2021 4.5k, Q1 2022 0, Q2 2022 4.0k
28 ROKU INC COM CL A ROKU ROKU 5,600 $460.0k0.64% 0.64% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 5.6k
29 QUALTEK SERVICES INC CLASS A COM CLASS A COM 300,000 $444.0k0.62% 0.62% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 354.3k, Q2 2022 300.0k -54.3k -54,269 -15.3%
30 DIGITALOCEAN HLDGS INC COM DOCN DOCN 10,000 $414.0k0.58% 0.58% ReducedShares held: Q3 2021 0, Q4 2021 4.5k, Q1 2022 25.0k, Q2 2022 10.0k -15.0k -15,000 -60.0%
31 ASPIRA WOMENS HEALTH INC COM COM 646,000 $380.0k0.53% 0.53% ReducedShares held: Q3 2021 1.1m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 646.0k -354.0k -354,000 -35.4%
32 ZETA GLOBAL HOLDINGS CORP CL A ZETA ZETA 72,500 $328.0k0.46% 0.46% UnchangedShares held: Q3 2021 135.0k, Q4 2021 135.0k, Q1 2022 72.5k, Q2 2022 72.5k
33 VISTA ENERGY S.A.B. DE C.V. SPONSORED ADS VIST VIST 41,500 $307.0k0.43% 0.43% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 41.5k
34 LEAP THERAPEUTICS INC COM LPTX LPTX 265,000 $305.0k0.43% 0.43% UnchangedShares held: Q3 2021 155.0k, Q4 2021 225.0k, Q1 2022 265.0k, Q2 2022 265.0k
35 ONCOCYTE CORP COM COM 330,000 $297.0k0.42% 0.42% UnchangedShares held: Q3 2021 330.0k, Q4 2021 330.0k, Q1 2022 330.0k, Q2 2022 330.0k
36 SURFACE ONCOLOGY INC COM SURF SURF 170,500 $280.0k0.39% 0.39% UnchangedShares held: Q3 2021 170.5k, Q4 2021 170.5k, Q1 2022 170.5k, Q2 2022 170.5k
37 FUBOTV INC COM FUBO FUBO 110,000 $272.0k0.38% 0.38% ReducedShares held: Q3 2021 253.7k, Q4 2021 230.5k, Q1 2022 192.0k, Q2 2022 110.0k -82.0k -82,000 -42.7%
38 CARDIFF ONCOLOGY INC COM CRDF CRDF 120,600 $265.0k0.37% 0.37% UnchangedShares held: Q3 2021 102.5k, Q4 2021 102.5k, Q1 2022 120.6k, Q2 2022 120.6k
39 NATERA INC COM NTRA NTRA 7,000 $248.0k0.35% 0.35% ReducedShares held: Q3 2021 25.9k, Q4 2021 32.4k, Q1 2022 12.5k, Q2 2022 7.0k -5.5k -5,500 -44.0%
40 ONCTERNAL THERAPEUTICS INC COM GTXI GTXI 210,000 $233.0k0.33% 0.33% ReducedShares held: Q3 2021 360.0k, Q4 2021 360.0k, Q1 2022 225.0k, Q2 2022 210.0k -15.0k -15,000 -6.7%
41 NEOLEUKIN THERAPEUTICS INC COM COM 199,000 $205.0k0.29% 0.29% UnchangedShares held: Q3 2021 239.0k, Q4 2021 212.5k, Q1 2022 199.0k, Q2 2022 199.0k
42 MEDICENNA THERAPEUTICS CORP COM MDNAF MDNAF 149,070 $173.0k0.24% 0.24% ReducedShares held: Q3 2021 350.0k, Q4 2021 152.5k, Q1 2022 152.5k, Q2 2022 149.1k -3.4k -3,430 -2.2%
43 ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAPY ADAPY 90,000 $153.0k0.21% 0.21% UnchangedShares held: Q3 2021 90.0k, Q4 2021 90.0k, Q1 2022 90.0k, Q2 2022 90.0k
44 LIVENT CORP COM COM 6,000 $136.0k0.19% 0.19% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 6.0k
45 DRAGANFLY INC. COM NEW DFLY DFLY 135,000 $122.0k0.17% 0.17% UnchangedShares held: Q3 2021 150.0k, Q4 2021 195.0k, Q1 2022 135.0k, Q2 2022 135.0k
46 MARKER THERAPEUTICS INC COM TPIVD TPIVD 354,400 $117.0k0.16% 0.16% UnchangedShares held: Q3 2021 439.4k, Q4 2021 354.4k, Q1 2022 354.4k, Q2 2022 354.4k
47 GRITSTONE BIO INC COM GRTS GRTS 47,500 $115.0k0.16% 0.16% UnchangedShares held: Q3 2021 74.0k, Q4 2021 40.0k, Q1 2022 47.5k, Q2 2022 47.5k
48 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 27,500 $114.0k0.16% 0.16% UnchangedShares held: Q3 2021 31.0k, Q4 2021 27.5k, Q1 2022 27.5k, Q2 2022 27.5k
49 AMAZON COM INC COM AMZN AMZN 1,000 $106.0k0.15% 0.15% ReducedShares held: Q3 2021 10.1k, Q4 2021 4.0k, Q1 2022 4.0k, Q2 2022 1.0k -3.0k -3,050 -75.3%
50 AUDACY INC CL A CL A 97,500 $92.0k0.13% 0.13% UnchangedShares held: Q3 2021 97.5k, Q4 2021 97.5k, Q1 2022 97.5k, Q2 2022 97.5k
51 IMMATICS N.V SHS IMTX IMTX 10,300 $90.0k0.13% 0.13% ReducedShares held: Q3 2021 63.5k, Q4 2021 63.5k, Q1 2022 37.5k, Q2 2022 10.3k -27.2k -27,200 -72.5%
52 CELLECTAR BIOSCIENCES INC COM PAR COM PAR 217,500 $88.0k0.12% 0.12% UnchangedShares held: Q3 2021 217.5k, Q4 2021 217.5k, Q1 2022 217.5k, Q2 2022 217.5k
53 CBDMD INC 8% SER A CUM PFD YCBD 8 PERP A YCBD 8 PERP A 22,000 $80.0k0.11% 0.11% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 22.0k
54 SUPERIOR DRILLING PRODS INC COM SDPI SDPI 80,000 $79.0k0.11% 0.11% UnchangedShares held: Q3 2021 117.5k, Q4 2021 107.5k, Q1 2022 80.0k, Q2 2022 80.0k
55 CYTOSORBENTS CORP COM NEW COM NEW 35,000 $77.0k0.11% 0.11% UnchangedShares held: Q3 2021 35.0k, Q4 2021 35.0k, Q1 2022 35.0k, Q2 2022 35.0k
56 ATARA BIOTHERAPEUTICS INC COM COM 9,200 $72.0k0.10% 0.10% UnchangedShares held: Q3 2021 116.9k, Q4 2021 9.2k, Q1 2022 9.2k, Q2 2022 9.2k
57 ENLIVEX THERAPEUTICS LTD COM ENLV ENLV 15,000 $68.0k0.10% 0.10% ReducedShares held: Q3 2021 82.5k, Q4 2021 25.0k, Q1 2022 25.0k, Q2 2022 15.0k -10.0k -10,000 -40.0%
58 LOTTERY COM INC COM COM 56,000 $63.0k0.09% 0.09% UnchangedShares held: Q3 2021 0, Q4 2021 61.0k, Q1 2022 56.0k, Q2 2022 56.0k
59 TRACON PHARMACEUTICALS INC COM NEW COM NEW 28,500 $57.0k0.08% 0.08% UnchangedShares held: Q3 2021 28.5k, Q4 2021 28.5k, Q1 2022 28.5k, Q2 2022 28.5k
60 CBDMD INC COM LEVB LEVB 125,000 $55.0k0.08% 0.08% UnchangedShares held: Q3 2021 102.5k, Q4 2021 125.0k, Q1 2022 125.0k, Q2 2022 125.0k
61 SIO GENE THERAPIES INC COMMON AXON AXON 146,500 $53.0k0.07% 0.07% UnchangedShares held: Q3 2021 185.0k, Q4 2021 185.0k, Q1 2022 146.5k, Q2 2022 146.5k
62 YALLA GROUP LTD ADS YALA YALA 13,500 $53.0k0.07% 0.07% UnchangedShares held: Q3 2021 13.5k, Q4 2021 13.5k, Q1 2022 13.5k, Q2 2022 13.5k
63 SQZ BIOTECHNOLOGIES CO COM SQZB SQZB 16,000 $51.0k0.07% 0.07% UnchangedShares held: Q3 2021 22.0k, Q4 2021 16.0k, Q1 2022 16.0k, Q2 2022 16.0k
64 AMPIO PHARMACEUTICALS INC COM COM 291,500 $49.0k0.07% 0.07% UnchangedShares held: Q3 2021 291.5k, Q4 2021 291.5k, Q1 2022 291.5k, Q2 2022 291.5k
65 CYTEIR THERAPEUTICS INC COM COM 15,000 $45.0k0.06% 0.06% UnchangedShares held: Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k, Q2 2022 15.0k
66 PDS BIOTECHNOLOGY CORP COM PDSB PDSB 12,000 $44.0k0.06% 0.06% ReducedShares held: Q3 2021 60.0k, Q4 2021 60.0k, Q1 2022 60.0k, Q2 2022 12.0k -48.0k -48,000 -80.0%
67 HELIUS MED TECHNOLOGIES INC COM CL A NEW COM CL A NEW 35,263 $42.0k0.06% 0.06% UnchangedShares held: Q3 2021 70.6k, Q4 2021 35.3k, Q1 2022 35.3k, Q2 2022 35.3k
68 OYSTER PT PHARMA INC COM OYST OYST 8,500 $37.0k0.05% 0.05% ReducedShares held: Q3 2021 31.5k, Q4 2021 13.5k, Q1 2022 13.5k, Q2 2022 8.5k -5.0k -5,000 -37.0%
69 BIOLINERX LTD SPONSORED ADS SPONSORED ADS 27,500 $35.0k0.05% 0.05% UnchangedShares held: Q3 2021 27.5k, Q4 2021 27.5k, Q1 2022 27.5k, Q2 2022 27.5k
70 SYROS PHARMACEUTICALS INC COM SYRS SYRS 35,000 $34.0k0.05% 0.05% UnchangedShares held: Q3 2021 52.5k, Q4 2021 21.5k, Q1 2022 35.0k, Q2 2022 35.0k
71 LOTTERY COM INC *W EXP 10/15/202 LTRYW LTRYW 125,000 $25.0k0.03% 0.03% UnchangedShares held: Q3 2021 0, Q4 2021 125.0k, Q1 2022 125.0k, Q2 2022 125.0k
72 INSTIL BIO INC COM COM 5,000 $23.0k0.03% 0.03% ReducedShares held: Q3 2021 10.0k, Q4 2021 10.0k, Q1 2022 10.0k, Q2 2022 5.0k -5.0k -5,000 -50.0%
73 ARAVIVE INC COM VSAR VSAR 18,777 $19.0k0.03% 0.03% AddedShares held: Q3 2021 23.5k, Q4 2021 10.0k, Q1 2022 17.5k, Q2 2022 18.8k +1.3k +1,277 7.3%
74 AKERNA CORP COM COM 128,000 $18.0k0.03% 0.03% UnchangedShares held: Q3 2021 232.0k, Q4 2021 128.0k, Q1 2022 128.0k, Q2 2022 128.0k
75 MOGO INC COM COM 19,491 $17.0k0.02% 0.02% ReducedShares held: Q3 2021 55.0k, Q4 2021 55.0k, Q1 2022 55.0k, Q2 2022 19.5k -35.5k -35,509 -64.6%
76 GENETRON HLDGS LTD ADS ADS 7,500 $13.0k0.02% 0.02% UnchangedShares held: Q3 2021 7.5k, Q4 2021 7.5k, Q1 2022 7.5k, Q2 2022 7.5k
77 AIRSCULPT TECHNOLOGIES INC COM AIRS AIRS 1,500 $9.0k0.01% 0.01% ReducedShares held: Q3 2021 0, Q4 2021 101.5k, Q1 2022 101.5k, Q2 2022 1.5k -100.0k -100,000 -98.5%
78 TRANSCODE THERAPEUTICS INC COM COM 6,500 $8.0k0.01% 0.01% ReducedShares held: Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k, Q2 2022 6.5k -43.5k -43,500 -87.0%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
NVIDIA CORPORATION NVDA NVDA 15,500 $4.2m15.5k shares
RANGE RES CORP RRC RRC 30,000 $911.0k30.0k shares
UPSTART HLDGS INC UPST UPST 5,500 $600.0k5.5k shares
COINBASE GLOBAL INC COIN COIN 3,000 $570.0k3.0k shares
GLOBAL E ONLINE LTD GLBE GLBE 12,500 $422.0k12.5k shares
BIOXCEL THERAPEUTICS INC 20,000 $418.0k20.0k shares
MATTERPORT INC MTTR MTTR 40,000 $325.0k40.0k shares
AFFIRM HLDGS INC AFRM AFRM 7,000 $324.0k7.0k shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 2,100 $249.0k2.1k shares
CURIS INC 80,000 $190.0k80.0k shares
AKERO THERAPEUTICS INC AKRO AKRO 10,000 $142.0k10.0k shares
AVADEL PHARMACEUTICALS PLC 10,500 $72.0k10.5k shares
APPLIED THERAPEUTICS INC APLT APLT 20,000 $42.0k20.0k shares
ACTINIUM PHARMACEUTICALS INC ATNM ATNM 6,500 $33.0k6.5k shares
NEKTAR THERAPEUTICS 6,000 $32.0k6.0k shares
AIRBNB INC ABNB ABNB 50 $9.0k50 shares
AVINGER INC 1,751 $6.0k1.8k shares
GENOCEA BIOSCIENCES INC GNCAQ GNCAQ 5,000 $6.0k5.0k shares